viewSynairgen PLC

Synairgen plc - Holding(s) in Company

RNS Number : 7919T
Synairgen plc
22 July 2020

Synairgen plc

("Synairgen" or the "Company")

Holding(s) in Company


Southampton, UK,: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it was informed on 22 July 2020 that Leonard Licht, a private investor, now holds 7,770,000 ordinary shares of 1 pence each in the capital of the Company, representing 5.20% of the Company's issued share capital.



Synairgen plc

+44 (0) 23 8051 2800

Richard Marsden (Chief Executive Officer)
John Ward (Finance Director)

finnCap - nominated adviser and broker

+44 (0) 20 7220 0500

Geoff Nash, Kate Bannatyne, Charlie Beeson (Corporate Finance)
Alice Lane, Manasa Patil (ECM)

Consilium Strategic Communications - financial media and investor relations adviser

+44 (0) 20 3709 5700

Mary-Jane Elliott, Sue Stuart, Olivia Manser


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Quick facts: Synairgen PLC

Price: 184.3

Market: AIM
Market Cap: £275.41 m

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Market report: FTSE flounders as imminent Brexit talks loom

The FTSE is mixed this Tuesday despite the weaker pound. Sterling is still battling no deal Brexit fears as the UK Prime Minister Boris Johnson threatens that if no progress on the talks with the EU is made week, preparations for a no deal will be ramped up. Britain’s biggest sports retailer...

1 week, 3 days ago